Institutional members access full text with Ovid®

Share this article on:

KRYPTON RED LASER PHOTOCOAGULATION OF THE OCULAR FUNDUS

Yannuzzi, Lawrence A. MD; Shakin, Jeffrey L. MD

doi: 10.1097/IAE.0b013e31823f9a1a
Reprint Article

Abstract: The theoretical rationale, the histopathologic evidence, and the preliminary clinical studies related to krypton red laser (KRL) photocoagulation of the ocular fundus are reviewed. The authors report on their experience with currently available laser systems using this wavelength (647.1 nm) for photocoagulation of retinal vascular proliferative diseases and chorioretinal diseases associated with exudative manifestations. A histopathologic and clinical comparison of argon blue-green laser (ABGL), the pure argon green laser (AGL), and the krypton yellow laser (KYL), with reference to photocoagulation treatment of the ocular fundus is also discussed.

Luesther T. Mertz Retinal Research Lab of the Manhattan Eye, Ear and Throat Hospital, New York, New York.

Reprint requests: Lawrence A. Yannuzzi, MD, 525 Park Avenue, New York, NY 10021.

© The Ophthalmic Communications Society, Inc.